DE60012140D1 - Verwendung von urintrypsininhibitor zur diagnose von aids - Google Patents

Verwendung von urintrypsininhibitor zur diagnose von aids

Info

Publication number
DE60012140D1
DE60012140D1 DE60012140T DE60012140T DE60012140D1 DE 60012140 D1 DE60012140 D1 DE 60012140D1 DE 60012140 T DE60012140 T DE 60012140T DE 60012140 T DE60012140 T DE 60012140T DE 60012140 D1 DE60012140 D1 DE 60012140D1
Authority
DE
Germany
Prior art keywords
aids
diagnosis
inhibitor
urintrypsin
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60012140T
Other languages
English (en)
Other versions
DE60012140T2 (de
Inventor
Marina N Papuashvili
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technologie Integrale Ltd
Original Assignee
Technologie Integrale Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technologie Integrale Ltd filed Critical Technologie Integrale Ltd
Priority to DE60012140T priority Critical patent/DE60012140T2/de
Application granted granted Critical
Publication of DE60012140D1 publication Critical patent/DE60012140D1/de
Publication of DE60012140T2 publication Critical patent/DE60012140T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE60012140T 1999-01-26 2000-01-24 Verwendung von urintrypsininhibitor zur diagnose von aids Expired - Lifetime DE60012140T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE60012140T DE60012140T2 (de) 1999-01-26 2000-01-24 Verwendung von urintrypsininhibitor zur diagnose von aids

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE19903034 1999-01-26
DE19903034 1999-01-26
DE19920704A DE19920704C1 (de) 1999-01-26 1999-05-05 Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS
DE19920704 1999-05-05
PCT/EP2000/000522 WO2000045175A1 (en) 1999-01-26 2000-01-24 Urinary trypsin inhibitor to diagnose aids
DE60012140T DE60012140T2 (de) 1999-01-26 2000-01-24 Verwendung von urintrypsininhibitor zur diagnose von aids

Publications (2)

Publication Number Publication Date
DE60012140D1 true DE60012140D1 (de) 2004-08-19
DE60012140T2 DE60012140T2 (de) 2005-09-08

Family

ID=26051490

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19920704A Expired - Fee Related DE19920704C1 (de) 1999-01-26 1999-05-05 Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS
DE60012140T Expired - Lifetime DE60012140T2 (de) 1999-01-26 2000-01-24 Verwendung von urintrypsininhibitor zur diagnose von aids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19920704A Expired - Fee Related DE19920704C1 (de) 1999-01-26 1999-05-05 Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS

Country Status (11)

Country Link
US (1) US6242197B1 (de)
EP (1) EP1147420B1 (de)
JP (1) JP3534703B2 (de)
AT (1) ATE271225T1 (de)
AU (1) AU770114B2 (de)
CA (1) CA2361000C (de)
DE (2) DE19920704C1 (de)
DK (1) DK1147420T3 (de)
ES (1) ES2225081T3 (de)
PT (1) PT1147420E (de)
WO (1) WO2000045175A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2832155B1 (fr) * 2001-11-09 2004-07-09 Lab Francais Du Fractionnement Anticorps stimulant la production d'il-1ra
WO2005040222A1 (en) * 2003-10-16 2005-05-06 Bayer Healthcare Llc Monoclonal antibodies for detection of urinary trypsin inhibitors
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
PL2691530T3 (pl) 2011-06-10 2019-02-28 Oregon Health & Science University Glikoproteiny i rekombinowane wektory CMV
EP2568289A3 (de) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US9925258B2 (en) 2015-10-02 2018-03-27 International Aids Vaccine Initiative Replication-competent VSV-HIV Env vaccines
EP4114428A1 (de) 2020-03-05 2023-01-11 Diamedica USA Inc. Ulinastatinpolypeptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2804979B2 (ja) * 1988-11-28 1998-09-30 日本ケミカルリサーチ株式会社 エイズ治療および阻害剤
JPH05304983A (ja) * 1992-04-27 1993-11-19 Nissin Food Prod Co Ltd ヒト尿中蛋白質分解酵素阻害蛋白質の定量のための物質および定量方法

Also Published As

Publication number Publication date
US6242197B1 (en) 2001-06-05
CA2361000A1 (en) 2000-08-03
AU770114B2 (en) 2004-02-12
DK1147420T3 (da) 2004-11-29
CA2361000C (en) 2009-12-22
ES2225081T3 (es) 2005-03-16
EP1147420A1 (de) 2001-10-24
PT1147420E (pt) 2004-12-31
DE60012140T2 (de) 2005-09-08
AU2439600A (en) 2000-08-18
JP3534703B2 (ja) 2004-06-07
JP2002535679A (ja) 2002-10-22
ATE271225T1 (de) 2004-07-15
WO2000045175A1 (en) 2000-08-03
DE19920704C1 (de) 2000-08-31
EP1147420B1 (de) 2004-07-14

Similar Documents

Publication Publication Date Title
DE60012140D1 (de) Verwendung von urintrypsininhibitor zur diagnose von aids
WO2002040634A3 (en) Expression miniarrays and uses thereof
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
DK1268847T3 (da) Ubiquitin-ligaseassay
TR199902904T2 (xx) Yeni bile�imler.
BR0317715A (pt) Composições e processos de uso de collajolie
DE59814262D1 (de) Wandler für teil- oder vollimplantierbare Hörgeräte
DE60331892D1 (de) Operationsinstrument und Verfahren zur Behandlung von Organvorfall
DE69625691T2 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
WO2003081201A3 (en) Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
MA28153A1 (fr) Acides nucléiques se liant spécifiquement à la ghréline biologiquement active
DE50207866D1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
TR199800841A2 (xx) �kame edilmi� 6- ve 7-aminotetrahidroisokinolinkarbon asitleri.
AU2002229677A1 (en) Soluble cyclic analogues of beta amyloid peptide
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
DE69920436D1 (de) Simulierte testverbindung zur untersuchung von drehschlagwerkzeugen
ATE403746T1 (de) Diagnose von restenose
BR0007702A (pt) Método e kit de diagnóstico para diagnose de endometriose
ATE322898T1 (de) Inhibitoren von mycobakterien
ATE337020T1 (de) Fettsaure analoge zur diagnose von kranzarterie erkrankungen
WO2000071081A3 (en) Methods of diagnosis and treatment of meniere disease
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
WO2002010763A3 (en) Marker for antidepressant therapy and methods related thereto
ATE449334T1 (de) Immobilisierte phosphatidsäuresonde

Legal Events

Date Code Title Description
8364 No opposition during term of opposition